Gold prices hold above $2700 after weak US CPI data. It hit an intraday high of $2708 and currently trading around $2706.62.
US CPI Data Insights
US CPI data from January 15, 2025, delivered inflationary perspectives; it moved up to 2.9% every year for December from the previous month, November, where it was recorded at 2.7%. It also moved above the predicted figure of 2.8%. On a monthly basis, it rose 0.4% against a forecast of 0.3%. The core CPI, however, removes food and energy's influence and rose to 3.2% from analysts' expectations of 3.3%. The major contributor to the rising CPI was a rise of 2.6% in energy. Gasoline prices surged 4.4%. Following this report, the US stock futures surged, and Treasury yields dropped. The mixed result is likely to see the interest rates at least unchanged in their next meeting with the Federal Reserve but might resort to cuts when inflation goes soft enough.
Increase in Rate Pause Probability
According to the CME Fed Watch tool, the chances of a rate pause have increased to 97.30% up from 93.60 % a week ago.
Technical Analysis: Support, Resistance, and Trading Strategy
Gold prices are holding above short-term moving averages 34 EMA and 55 EMA and long-term moving averages (200 EMA) in the 4-hour chart. Immediate support is at $2,670, and a break below this level will drag the yellow metal $2660/$2650/$2,630,$2600/ $2,570, $2,559, $2,536, and eventually $2,500. The near-term resistance is at $2710, with potential price targets at $2725/ $2,750-/$2775. It is good to buy on dips around $2680, with a stop-loss at $2,640 for a target price of $2,775/$2790.


Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026
Spying, Southampton and economic pressure cooker of the ‘richest match in football’
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
AI-Driven Memory Chip Prices May Be Skewing U.S. Inflation Data, Fed Minutes Suggest
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Silver Sheds Gains in Gold’s Wake as Bears Probe Key $74.50 Support; Sell-on-Rallies Eyes $70
NHS shakeup: if it sounds like we’ve been here before, it’s because we have 



